BIOMAT Database Logo BIOMAT Database Logo

Synthesis and biological activity of some 1,3-dihydro-2H-3-benzazepin-2-ones with a piperazine moiety as bradycardic agents. 2010

Hong-Yu Liang, and Deng-Qing Zhang, and Yun Yue, and Zhe Shi, and Sheng-Yin Zhao
Department of Chemistry, Donghua University, Shanghai, P.R. China.

A series of 1,3-dihydro-2H-3-benzazepin-2-ones with a piperazine moiety were designed and synthesized by treating the common intermediate of 1,3-dihydro-7,8-dimethoxy-3-[3-(1-piperazinyl)propyl]-2H-3-benzazepin-2-ones with a variety of N-aryl-2-chloroacetamides and acyl chlorides. Their structures have been characterized by (1)H-NMR, MS, and elemental analysis. The title compounds were evaluated for their bradycardic activity in vitro. Most of the synthesized compounds exhibited some vasorelaxant activity and heart-rate-reducing activity with bradycardic potency.

UI MeSH Term Description Entries
D008297 Male Males
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D002316 Cardiotonic Agents Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). Cardiac Stimulant,Cardiac Stimulants,Cardioprotective Agent,Cardioprotective Agents,Cardiotonic,Cardiotonic Agent,Cardiotonic Drug,Inotropic Agents, Positive Cardiac,Myocardial Stimulant,Myocardial Stimulants,Cardiotonic Drugs,Cardiotonics,Agent, Cardioprotective,Agent, Cardiotonic,Drug, Cardiotonic,Stimulant, Cardiac,Stimulant, Myocardial
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001552 Benzazepines Compounds with BENZENE fused to AZEPINES.
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014664 Vasodilation The physiological widening of BLOOD VESSELS by relaxing the underlying VASCULAR SMOOTH MUSCLE. Vasodilatation,Vasorelaxation,Vascular Endothelium-Dependent Relaxation,Endothelium-Dependent Relaxation, Vascular,Relaxation, Vascular Endothelium-Dependent,Vascular Endothelium Dependent Relaxation
D014665 Vasodilator Agents Drugs used to cause dilation of the blood vessels. Vasoactive Antagonists,Vasodilator,Vasodilator Agent,Vasodilator Drug,Vasorelaxant,Vasodilator Drugs,Vasodilators,Vasorelaxants,Agent, Vasodilator,Agents, Vasodilator,Antagonists, Vasoactive,Drug, Vasodilator,Drugs, Vasodilator
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats

Related Publications

Hong-Yu Liang, and Deng-Qing Zhang, and Yun Yue, and Zhe Shi, and Sheng-Yin Zhao
Structural and biological investigation of ferrocene-substituted 3-methylidene-1,3-dihydro-2H-indol-2-ones.
February 2009, Dalton transactions (Cambridge, England : 2003),
Hong-Yu Liang, and Deng-Qing Zhang, and Yun Yue, and Zhe Shi, and Sheng-Yin Zhao
New synthesis of 1,3-dihydro-1,4-benzodiazepin-2(2H)-ones and 3-amino-1,3-dihydro-1,4-benzodiazepin-2(2H)-ones: Pd-catalyzed cross-coupling of imidoyl chlorides with organoboronic acids.
April 2003, The Journal of organic chemistry,
Hong-Yu Liang, and Deng-Qing Zhang, and Yun Yue, and Zhe Shi, and Sheng-Yin Zhao
Synthesis and antitrichinellosis activity of some 2-substituted-[1,3]thiazolo[3,2-a]benzimidazol-3(2H)-ones.
October 2005, Bioorganic & medicinal chemistry,
Hong-Yu Liang, and Deng-Qing Zhang, and Yun Yue, and Zhe Shi, and Sheng-Yin Zhao
Substituted 1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-ones as potential antiinflammatory agents.
October 1990, Journal of medicinal chemistry,
Hong-Yu Liang, and Deng-Qing Zhang, and Yun Yue, and Zhe Shi, and Sheng-Yin Zhao
4-Aroyl-1,3-dihydro-2H-imidazol-2-ones, a new class of cardiotonic agents.
December 1982, Journal of medicinal chemistry,
Hong-Yu Liang, and Deng-Qing Zhang, and Yun Yue, and Zhe Shi, and Sheng-Yin Zhao
3-Substituted, 3-(4-pyridinylmethyl)-1,3-dihydro-1-phenyl-2H-indol-2-ones as acetylcholine release enhancers: synthesis and SAR.
October 1993, Journal of medicinal chemistry,
Hong-Yu Liang, and Deng-Qing Zhang, and Yun Yue, and Zhe Shi, and Sheng-Yin Zhao
Synthesis and evaluation of metallocene containing methylidene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors.
June 2011, Metallomics : integrated biometal science,
Hong-Yu Liang, and Deng-Qing Zhang, and Yun Yue, and Zhe Shi, and Sheng-Yin Zhao
Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.
December 2008, Bioorganic & medicinal chemistry letters,
Hong-Yu Liang, and Deng-Qing Zhang, and Yun Yue, and Zhe Shi, and Sheng-Yin Zhao
5-ARYL-1,3-DIHYDRO-2H-1,3,4-BENZOTRIAZEPIN-2-ONES.
May 1964, Journal of medicinal chemistry,
Hong-Yu Liang, and Deng-Qing Zhang, and Yun Yue, and Zhe Shi, and Sheng-Yin Zhao
Synthesis and biological evaluation of 3-ethylidene-1,3-dihydro-indol-2-ones as novel checkpoint 1 inhibitors.
January 2006, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!